Higher Serum Bisphenol A Levels in Diabetic Hemodialysis Patients

Basit Öğe Kaydı
dc.authoridTURGUT, FARUK/0000-0003-1910-7433
dc.authoridSungur, Sana/0000-0001-7370-8972
dc.contributor.authorTurgut, Faruk
dc.contributor.authorSungur, Sana
dc.contributor.authorOkur, Ramazan
dc.contributor.authorYaprak, Mustafa
dc.contributor.authorOzsan, Muge
dc.contributor.authorUstun, Ihsan
dc.contributor.authorGokce, Cumali
dc.date.accessioned2024-09-18T20:04:32Z
dc.date.available2024-09-18T20:04:32Z
dc.date.issued2016
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractBackground: Bisphenol A (BPA) has been implicated as an 'endocrine disruptor'. We aimed at exploring the association between serum BPA levels and patient characteristics, particularly the presence of diabetes mellitus, and laboratory parameters in hemodialysis patients. Methods: This study included 47 chronic hemodialysis patients. Patient characteristics were recorded. Blood was drawn before and after hemodialysis session. Serum BPA levels were measured by the high-performance-liquid-chromatography and laboratory parameters were measured by using standard methods. Results: In hemodialysis patients, postdialysis serum BPA levels were significantly higher than predialysis after a single hemodialysis session (5.57 +/- 1.2 vs. 4.06 +/- 0.73, p < 0.0001). Predialysis serum BPA levels were significantly higher in patients with diabetes than non-diabetics (4.4 +/- 0.6 vs. 3.9 +/- 0.7, p = 0.025). No association was found between serum BPA levels and patient characteristics, and particularly laboratory parameters. Conclusion: Serum BPA levels were rising significantly after a single dialysis session. Diabetic hemodialysis patients had higher predialysis serum BPA levels. (C) 2016 S. Karger AG, Baselen_US
dc.identifier.doi10.1159/000445203
dc.identifier.endpage82en_US
dc.identifier.issn0253-5068
dc.identifier.issn1421-9735
dc.identifier.issue1en_US
dc.identifier.pmid27193155en_US
dc.identifier.scopus2-s2.0-84969662890en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage77en_US
dc.identifier.urihttps://doi.org/10.1159/000445203
dc.identifier.urihttps://hdl.handle.net/20.500.12483/8231
dc.identifier.volume42en_US
dc.identifier.wosWOS:000377999600015en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofBlood Purificationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBisphenol Aen_US
dc.subjectChronic kidney diseaseen_US
dc.subjectHemodialysisen_US
dc.subjectDiabetes mellitusen_US
dc.titleHigher Serum Bisphenol A Levels in Diabetic Hemodialysis Patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full text
Boyut:
129.04 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu